Literature DB >> 8242379

Ventral mesencephalic delta opioid receptors are involved in modulation of basal mesolimbic dopamine neurotransmission: an anatomical localization study.

D P Devine1, P Leone, W A Carlezon, R A Wise.   

Abstract

Microdialysis was used to examine the anatomical localization of mesencephalic delta opioid receptors that participate in modulation of mesolimbic dopamine (DA) neurotransmission. Independent groups of rats were injected with DPDPE into the ventral tegmental area (VTA) or interpeduncular nucleus (IPN). Extracellular nucleus accumbens DA and DOPAC concentrations were elevated after DPDPE injections into either site, but injections into the VTA were effective at lower doses than were injections into the IPN. Thus, it appears that the DA-modulating actions of DPDPE are mediated in the VTA rather than the IPN.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242379     DOI: 10.1016/0006-8993(93)90843-c

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  6 in total

Review 1.  Forebrain substrates of reward and motivation.

Authors:  Roy A Wise
Journal:  J Comp Neurol       Date:  2005-12-05       Impact factor: 3.215

2.  Stress-induced activation of ventral tegmental mu-opioid receptors reduces accumbens dopamine tone by enhancing dopamine transmission in the medial pre-frontal cortex.

Authors:  Emanuele Claudio Latagliata; Alessandro Valzania; Tiziana Pascucci; Paolo Campus; Simona Cabib; Stefano Puglisi-Allegra
Journal:  Psychopharmacology (Berl)       Date:  2014-03-29       Impact factor: 4.530

3.  Effect of novel nociceptin/orphanin FQ-NOP receptor ligands on ethanol drinking in alcohol-preferring msP rats.

Authors:  D Economidou; A Fedeli; R Martin Fardon; F Weiss; M Massi; R Ciccocioppo
Journal:  Peptides       Date:  2006-12       Impact factor: 3.750

4.  Two delta opioid receptor subtypes are functional in single ventral tegmental area neurons, and can interact with the mu opioid receptor.

Authors:  Elyssa B Margolis; Wakako Fujita; Lakshmi A Devi; Howard L Fields
Journal:  Neuropharmacology       Date:  2017-06-21       Impact factor: 5.250

Review 5.  Endogenous opioid system: a promising target for future smoking cessation medications.

Authors:  Haval Norman; Manoranjan S D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2017-03-11       Impact factor: 4.530

6.  Attenuation of ethanol self-administration and of conditioned reinstatement of alcohol-seeking behaviour by the antiopioid peptide nociceptin/orphanin FQ in alcohol-preferring rats.

Authors:  Roberto Ciccocioppo; Daina Economidou; Amalia Fedeli; Stefania Angeletti; Friedbert Weiss; Markus Heilig; Maurizio Massi
Journal:  Psychopharmacology (Berl)       Date:  2003-11-18       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.